Luther King Capital Management (LKCM)’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Luther King Capital Management (LKCM)'s CDNA Position: Q4 2021 in Review
Luther King Capital Management (LKCM) sold out of CareDx (CDNA) in Q4 2021, closing a stake of 41,760 shares — an estimated $2.65M sold.
Luther King Capital Management (LKCM) first reported a position in CDNA in Q2 2020 and held it in 6 quarters. The position peaked at $3.82M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Luther King Capital Management (LKCM) reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
- Luther King Capital Management (LKCM) sold 41,760 CareDx shares in Q4 2021, an estimated $2.65M.
- Luther King Capital Management (LKCM) first reported a position in CareDx in Q2 2020 and held it in 6 quarters.
- Luther King Capital Management (LKCM)'s CareDx position peaked at $3.82M in Q2 2021.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q4 2021, filed 14 Feb 2022.